NAD+ and Supplement Claims: Reading the Evidence
NAD+ is essential to metabolism. That does not mean raising it with a supplement produces the outcomes advertised.
By Hypergevity Editorial Team · Published September 3, 2026 · Updated September 3, 2026 · 8 min read
- NAD+ is a coenzyme central to energy metabolism and cellular repair pathways.
- NAD+ precursors include niacin and other forms of vitamin B3, plus NR and NMN.
- Precursor supplements can raise blood NAD+ markers; clinical outcome benefits in humans are not established.
- Dietary supplements are not FDA-approved for effectiveness before sale.
- Third-party testing and clinician disclosure matter more than marketing language.
NAD+ (nicotinamide adenine dinucleotide) is genuinely important. It participates in the reactions that convert food into usable energy and in enzyme systems involved in DNA repair and cellular signalling. Levels are reported to decline with age, and that observation launched an entire product category.
The gap between mechanism and outcome
Two claims are often blurred together. The first — that precursor supplementation can raise measurable NAD+ markers — has support in human trials. The second — that doing so improves how long or how well people live — does not. Most of the striking findings come from cell and animal studies, which frequently fail to translate.
| Form | What it is | Status |
|---|---|---|
| Niacin / nicotinamide (vitamin B3) | Established essential nutrient and NAD+ precursor | Established nutrient requirement; high-dose niacin has known side effects such as flushing and liver considerations |
| Nicotinamide riboside (NR) | NAD+ precursor sold as a supplement | Human trials show it can raise NAD+ markers; clinical outcome benefits are not established |
| Nicotinamide mononucleotide (NMN) | NAD+ precursor sold as a supplement | Human data are limited; regulatory status in the U.S. has been contested |
| IV NAD+ infusions | Intravenous administration marketed by clinics | Marketed claims generally outpace published human evidence; carries procedural risk and cost |
In the United States, dietary supplements do not require FDA approval for effectiveness before being sold. Manufacturers are responsible for safety and labeling accuracy, and enforcement is largely after the fact. That is why third-party testing and clinician oversight matter.
How to evaluate a product
- Look for independent third-party testing for identity and purity
- Check whether cited studies were done in humans, and at what dose and duration
- Be wary of claims to treat, cure or prevent disease — those are drug claims
- Disclose every supplement to your clinician, especially with prescription medication
- Prefer spending on the fundamentals first: training, sleep, nutrition, preventive care
For the broader pattern of how longevity claims get overstated, see our guide on evaluating longevity marketing.
Frequently asked questions
- Do NAD+ supplements work?
- Precursors can raise measurable NAD+ levels in humans, but evidence that this improves clinical outcomes such as healthspan or lifespan is not established.
- Are NAD+ IV drips better than oral supplements?
- Marketing claims for IV NAD+ generally exceed the published human evidence, and infusions add cost and procedural risk. Discuss with a clinician before considering one.
- Is NAD+ supplementation safe?
- Safety depends on the specific compound, dose and your medical history. Disclose supplements to your clinician, particularly alongside prescription medication.
Get supplement questions answered by a clinician
Hypergevity clinical care includes reviewing what you are taking. Start a confidential intake to discuss it with a licensed U.S. provider.
References
- Niacin — Office of Dietary Supplements, National Institutes of Health
- Dietary Supplements: What You Need to Know — Office of Dietary Supplements, National Institutes of Health
- What Do We Know About Healthy Aging? — National Institute on Aging (NIH)
Prescription products require an online consultation with a healthcare professional who will determine if a prescription is appropriate. You will be notified through email, text/SMS, or your online Hypergevity portal if approved. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. If receiving treatment for other conditions, your provider may prescribe FDA-approved generic or brand prescription drugs. If you are unsure, always ask your provider which medication they are prescribing.